Chinese cardiovascular firm Sihuan heads for Hong Kong IPO
This article was originally published in Scrip
Executive Summary
The Chinese company Sihuan Pharmaceutical Holdings Group is aiming to raise up to $816 million through an initial public offering in Hong Kong, which it will use mainly to fund mergers and acquisitions and to bolster R&D.